Moreover, FC is directly linked to the inflammation and fibrosis associated with MASLD, possibly through the mechanism of increased toll-like receptor 4 (TLR4) signaling, which also triggers hepatocyte death by activating c-Jun N-terminal protein kinase 1 (JNK1). Here, TLR4 is linked to metabolic dysfunction-associated steatotic liver disease.